Early research (Phase 1)Study completedNCT01462136What this trial is testingPK Study of ACHN-490 Injection in Renally Impaired SubjectsWho this might be right forRenal Insufficiency Achaogen, Inc. 24
Early research (Phase 1)Study completedNCT01571999What this trial is testingStudy to Assess the Safety and PK of GSK573719 and GSK573719/GW642444(VI) Combination in Healthy Subjects and Subjects With Severe Renal ImpairmentWho this might be right forPulmonary Disease, Chronic Obstructive GlaxoSmithKline 17
Early research (Phase 1)Study completedNCT02084199What this trial is testingStudy to Evaluate GLPG0634 in Subjects With Renal Impairment Compared to Healthy SubjectsWho this might be right forRenal Impairment Lakefront Biotherapeutics NV 24
Early research (Phase 1)Study completedNCT03961932What this trial is testingSafety and Pharmacokinetics of Linzagolix in Female Subjects With Normal and Impaired Renal FunctionWho this might be right forRenal ImpairmentHealthy Participants ObsEva SA 33
Early research (Phase 1)Study completedNCT03844555What this trial is testingElafibranor Pharmacokinetic Parameters in Renal Impaired PatientsWho this might be right forRenal ImpairmentRenal InsufficiencyKidney Diseases+1 more Genfit 23
Early research (Phase 1)Study completedNCT01791855What this trial is testingPF-04634817 Renal Impairment StudyWho this might be right forRenal Insufficiency Pfizer 32
Early research (Phase 1)Study completedNCT02347046What this trial is testingClinical Pharmacology of FYU-981 (Subjects With Renal Insufficiency)Who this might be right forRenal InsufficiencyHealthy Fuji Yakuhin Co., Ltd. 18
Early research (Phase 1)Ended earlyNCT01675973What this trial is testingAssess the Effect of Severe Renal Impairment on the Pharmacokinetics, as Well as Safety/Tolerability, of RanolazineWho this might be right forSevere Renal Impairment Gilead Sciences 4
Early research (Phase 1)Study completedNCT03043482What this trial is testingInvestigate the Safety, Tolerability, and Pharmacokinetics of VS 105Who this might be right forChronic-kidney Disease Stage 5D on Stable Hemodialysis Vidasym, Inc. 69
Not applicableStudy completedNCT01623661What this trial is testingEffect of Hypertonic Sodium Chloride on Urinary Biomarkers in Healthy Subjects and Patients With Chronic Kidney DiseaseWho this might be right forNephropathy Regional Hospital Holstebro 47
Early research (Phase 1)Study completedNCT02606084What this trial is testingAssess the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered EsketamineWho this might be right forRenal ImpairmentHealthy Janssen Research & Development, LLC 32
Not applicableUnknownNCT03108222What this trial is testingPhosphorus Absorption in Healthy Adults and in Patients With Moderate Chronic Kidney DiseaseWho this might be right forChronic Kidney Disease Mineral and Bone Disorder Purdue University 20
Early research (Phase 1)Study completedNCT04476849What this trial is testingInvestigate the Effect of Renal Impairment on the Safety and Tolerability of Fezolinetant Compared to Participants With Normal Renal FunctionWho this might be right forHealthy VolunteersRenal Impairment Astellas Pharma Global Development, Inc. 27
Early research (Phase 1)Study completedNCT00999336What this trial is testingDetermine the Pharmacokinetics, Pharmacodynamics, and Tolerabiltiy of Betrixaban in Patients With Mild, Moderate, and Severe Renal ImpairmentWho this might be right forRenal Impairment Portola Pharmaceuticals 32
Not applicableStudy completedNCT05465863What this trial is testingHumoral and Cellular İmmune Response to SARS-CoV-2 mRNA BNT162b2 Vaccine in Children With Chronic Kidney DiseasesWho this might be right forChronic Kidney Disease 5DChronic Kidney Disease 5T Istanbul University - Cerrahpasa 101
Early research (Phase 1)Study completedNCT03660241What this trial is testingA Renal Impairment Study for PF-04965842Who this might be right forRenal Impairment Pfizer 23
Early research (Phase 1)Study completedNCT05704556What this trial is testingEvaluation of the Pharmacokinetics and Safety of VX-548 in Participants With Renal ImpairmentWho this might be right forPain Vertex Pharmaceuticals Incorporated 38
Early research (Phase 1)Study completedNCT03252002What this trial is testingClinical Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Pharmacodynamic Effects of a Single and Multiple Oral BAY1101042 Tablet Doses in Healthy Male SubjectsWho this might be right forHealthy Volunteer Bayer 96
Early research (Phase 1)WithdrawnNCT05406219What this trial is testingLearn How the Study Treatment BAY2395840 Moves Into, Through and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Moderate Reduced Kidney Function and in Healthy Male and Female Participants With Normal Kidney FunctionWho this might be right forDiabetic Neuropathic PainRenal ImpairmentHealthy Volunteers Bayer
Early research (Phase 1)Study completedNCT06657560What this trial is testingPharmacokinetics, Dialysability and Safety of HRS-9231 in Healthy Volunteers and in Patients With Impaired Renal FunctionWho this might be right forContrast-Enhanced Magnetic Resonance Imaging Detection Shanghai Shengdi Pharmaceutical Co., Ltd 41